Description
This product is a recombinant human antibody KTT-B8 that recognizes MDA-ApoB100. KTT-B8 directed towards one oxidized fragment of apolipoprotein B and can be used for treatment study of atherosclerosis.
Target
MDA-ApoB100
Target Alias Name
Malondialdehyde (MDA)-modified apoB-100 peptide
Isotype/Mimetic
Human IgG1
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression